text: Imperative Care Announces $85 Million Series C Financing for Innovative Stroke Treatments | Business Wire
  CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company's portfolio, which is composed of the latest advances in neurovascular devices treating ischemic and hemorrhagic strokes.